<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61142</article-id><article-id pub-id-type="doi">10.7554/eLife.61142</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Epidemiological transition to mortality and re-fracture following an initial fracture</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-198070"><name><surname>Ho-Le</surname><given-names>Thao Phuong</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8387-1893</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-199424"><name><surname>Tran</surname><given-names>Thach Son</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224362"><name><surname>Bliuc</surname><given-names>Dana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199425"><name><surname>Pham</surname><given-names>Hanh M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199426"><name><surname>Frost</surname><given-names>Steven A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199427"><name><surname>Center</surname><given-names>Jacqueline R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-199428"><name><surname>Eisman</surname><given-names>John A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" corresp="yes" id="author-199429"><name><surname>Nguyen</surname><given-names>Tuan V</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Healthy Aging Theme</institution>, <institution>Garvan Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff><aff id="aff2"><institution content-type="dept">Fertility Department</institution>, <institution>Andrology and Fertility Hospital of Hanoi</institution>, <addr-line><named-content content-type="city">Hanoi</named-content></addr-line>, <country>Viet Nam</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-143776"><name><surname>Shoback</surname><given-names>Dolores</given-names></name><role>Reviewing editor</role><aff><institution>University of California, San Francisco</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>t.ho-le@garvan.org.au</email> (TH);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>t.nguyen@garvan.org.au</email> (TN);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>02</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e61142</elocation-id><history><date date-type="received"><day>16</day><month>07</month><year>2020</year></date><date date-type="accepted"><day>25</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Ho-Le et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Ho-Le et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-61142-v1.pdf"/><abstract><p>This study sought to redefine the concept of fracture risk that includes refracture and mortality. We analysed data obtained from 2046 women and 1205 men aged 60+ years, whose health status, including bone mineral density (BMD), has been monitored. During the 20-year follow-up period, among 632 women and 184 men with a first incident fracture, the risk of sustaining a second fracture was higher in women (36%, n=229) than in men (22%, n=41), but mortality risk was higher in men (41%, n=75) than in women (25%, n=156). Key predictors of subsequent fracture risk included advancing age (hazard ratio [HR] 1.17; 95%CI, 1.08-1.26) and low BMD (HR 1.41; 1.23-1.61). Predictors of mortality were male gender (HR 2.4; 1.79-3.21), advancing age (1.67; 1.53-1.83), and lower femoral neck BMD (1.16; 1.01-1.33). These results were incorporated into a prediction model to aid patient-doctor discussion about fracture vulnerability and treatment decisions.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>The Australian National Health and Medical Research Council grant,NHMRC 276413</award-id><principal-award-recipient><name><surname>Nguyen</surname><given-names>Tuan V</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Thao Phuong Ho-Le, received the Christine &amp; T. Jack Martin Research travel grant from AMGEN &amp; Australian and New Zealand Bone and Mineral Society..</p></fn><fn fn-type="conflict" id="conf3"><p>Jacqueline R Center, has given educational talks for and received travel expenses from Amgen, Merck Sharp &amp; Dohme, Novartis, Sanofi-Aventis. She has received travel expenses from Merck Sharp &amp; Dohme, Amgen and Aspen..</p></fn><fn fn-type="conflict" id="conf4"><p>John A Eisman, has served as consultant on Scientific Advisory Boards for Amgen, 35 Eli Lilly, Merck Sharp &amp; Dohme, Novartis, Sanofi-Aventis, Servier and deCode..</p></fn><fn fn-type="conflict" id="conf5"><p>Tuan V Nguyen, has received  honoraria for consulting and speaking in symposia sponsored by Merck Sharp &amp; Dohme,  Roche, Sanofi-Aventis, Novartis, and Bridge Healthcare Pty Ltd (Vietnam)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was approved by the Ethics Committee of St Vincent's Hospital (Sydney) (HREC reference number: 13/254) and carried out according to the Australian National Health and Medical Research Council (NHMRC) Guidelines, consistent with the Declaration of Helsinki (established in 1964 and revised in 1989) (US Food and Drug Administration). All participants have provided written informed consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 3, Figure 3 - figure supplement 1, and Figure 3 - figure supplement 2.</p></sec><supplementary-material><ext-link xlink:href="elife-61142-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>